艾司洛尔联合胺碘酮治疗老年室性心律失常的疗效  

Efficacy of Esmolol Combined With Amiodarone in the Treatment of Senile Ventricular Arrhythmia

作　　者：黄建平 徐秀良 

机构地区：[1]福建医科大学附属宁德市医院心血管内科,福建宁德352100

出　　处：《中国卫生标准管理》2017年第23期79-81,共3页China Health Standard Management

摘　　要：目的探讨艾司洛尔联合胺碘酮治疗老年室性心律失常的临床疗效。方法收集我院2016年1月—2017年1月入院的160例室性心律失常老年患者随机分为两组,对照组患者采取常规方案,给予胺碘酮治疗,实验组患者则在以上基础上加用艾司洛尔,比较两组患者总体治疗效果评价、治疗前后心脏电生理参数与治疗期间不良反应发生率等。结果实验组患者显效率与总有效率高于对照组(P<0.05);两组患者心动过速、甲状腺功能异常、血压骤低、消化道症状与总体不良反应发生率的差异不具有统计学意义(P>0.05)。结论艾司洛尔联合胺碘酮治疗老年室性心律失常的临床疗效显著,具有借鉴性。Objective To investigate the clinical efficacy of esmolol combined with amiodarone in the treatment of senile ventricular arrhythmia. Methods 160 patients with ventricular arrhythmia were enrolled in our hospital from January 2016 to January 2017. They were randomly divided into two groups. The patients in the control group were treated with conventional regimen and treated with amiodarone. The patients in the experimental group plus esmolol. The overall therapeutic effect, the cardiac electrophysiological parameters and the incidence of adverse reactions during treatment were compared between the two groups. Results The effective rate and total effective rate of the patients in the experimental group were significantly higher than those in the control group（P 0.05）. There was no statistically significant difference between the two groups in patients with tachycardia, abnormal thyroid function, low blood pressure, and the incidence of total adverse reactions（P 0.05）. Conclusion Theclinical efficacy of esmolol combined with amiodarone in the treatment of senile ventricular arrhythmia is significant.

关 键 词：艾司洛尔 胺碘酮 室性心律失常 不良反应 

分 类 号：R541[医药卫生—心血管疾病]